JAMES COOKSEY: Open Payments
NPI 1497241285 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 54 payments from 12 companies in 2025. Trend: 2023 $894 · 2024 $1,076 · 2025 $1,063
Food & beverage: $919Education: $144
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $186 |
| GENZYME CORPORATION | 6 | $178 |
| Novartis Pharmaceuticals Corporation | 10 | $165 |
| LEO Pharma Inc. | 11 | $139 |
| ABBVIE INC. | 5 | $116 |
| E.R. Squibb & Sons, L.L.C. | 3 | $105 |
| Regeneron Healthcare Solutions, Inc. | 3 | $55 |
| Arcutis Biotherapeutics, Inc. | 2 | $34 |
| PFIZER INC. | 1 | $29 |
| Lilly USA, LLC | 1 | $24 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, ADBRY, Sotyktu, COSENTYX, Zoryve, CIBINQO.
Industry payments across MS — which companies pay providers there.
